27 patient in all | Data available | |
---|---|---|
Generall findings: | ||
Age distribution | 24–88 | 27/27 |
Gender | 15 M/12 F | 27/27 |
Immuno compromised | 10 | 24/27 |
Diabetes mellitus | 2 | 24/27 |
History of cancer | 5 | 24/27 |
Flu like symtoms | 7 | 15/27 |
Initial therapy: | In total | |
Only corticosteroide | 12 | 22/27 |
Corticosteroids with additional antibiotics | 8 | |
Diagnostic: | In total | |
Direct Gram stain | 6 pos/9 neg | 15/27 |
Aquous culture | 18 pos/3 neg | 21/27 |
Intraocular culture | 7 pos/ 2 neg | 9/27 |
Blood culture | 3 pos/10 neg | 13/27 |
Final therapy: | In total | |
Systemic (Intravenous, oral) | 24/2 | 26/27 |
Ampicillin | 15 | |
Gentamicin | 7 | |
Penicilline | 6 | |
Vancomycin | 3 | |
Meropenem | 2 | |
Erythromycin | 1 | |
Tetracycline | 1 | |
Ciprofloxacin | 1 | |
Tobramycin | 1 | |
Ceftazidime | 1 | |
Clindamycin | 1 | |
Combined | 12 | |
Ocular additive | ||
Paraocular (subconjunctival/-tenon/ intraorbital) | 5/1/1 | |
Intraocular (intracameral/ -vitreal) | 2/8 | |
Time between onset and treament | 4 to 32 days | 24/27 |